A longitudinal study found that in patients with suspected non-AD pathology (SNAP)who exhibited tau pathology without Aβ deposition, higher CSF-PGRN levels were linked to faster Aβ plaque formation, suggesting that PGRN plays a role in neurodegeneration beyond AD [107]. The gene discussed is MAPT; the disease is Alzheimer disease.